Matches in Wikidata for { <http://www.wikidata.org/entity/Q95519175> ?p ?o ?g. }
Showing items 1 to 27 of
27
with 100 items per page.
- Q95519175 description "scholarly article published 25 June 2019" @default.
- Q95519175 description "wetenschappelijk artikel" @default.
- Q95519175 description "наукова стаття" @default.
- Q95519175 name "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 name "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 type Item @default.
- Q95519175 label "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 label "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 prefLabel "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 prefLabel "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 P1476 Q95519175-709A04E0-6052-4F4F-8C6A-AB45CA8B0D8D @default.
- Q95519175 P31 Q95519175-605b4822-733f-4061-84dd-53d6540f2e41 @default.
- Q95519175 P31 Q95519175-C98C6745-747B-42DC-8599-481A177E0959 @default.
- Q95519175 P577 Q95519175-7FE47F7F-679C-4C2E-86B3-34869785EDCB @default.
- Q95519175 P698 Q95519175-7406CF0D-6C79-45D1-8246-2611E1E98F33 @default.
- Q95519175 P921 Q95519175-93E8C610-DC62-459D-8004-71F2E8BC935B @default.
- Q95519175 P921 Q95519175-AD695BE0-3649-439C-9FB0-B70D99664F5B @default.
- Q95519175 P921 Q95519175-DAE0B7F6-9D5E-427F-891C-8595AEBFD22F @default.
- Q95519175 P698 31233294 @default.
- Q95519175 P1476 "Pharmacoeconomic Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older" @default.
- Q95519175 P31 Q13442814 @default.
- Q95519175 P31 Q7318358 @default.
- Q95519175 P577 "2019-06-25T00:00:00Z" @default.
- Q95519175 P698 "31233294" @default.
- Q95519175 P921 Q16 @default.
- Q95519175 P921 Q35869 @default.
- Q95519175 P921 Q8564098 @default.